Desk› Healthcare› Brooks Laboratories Ltd

Brooks Laboratories Ltd

BSE 533543 BROOKS INE650L01011

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

18 filings · 4 material · busiest 2026-08-12 and 2026-08-13

What it files

Newspaper Publication3 General3 Annual Report2 AGM / EGM2 Book Closure1 Board Outcome1 Results1 Board Meeting1

Filings

18 in the window

21 August 2026

Annual Report

Reg. 34 (1) Annual Report.

Addendum to the Notice of 24th Annual General Meeting of the Company.

Others / Reg. 34 (1) Annual Report View filing →
21 August 2026

AGM / EGM

Addendum To The Notice Of 24Th Annual General Meeting Of The Company.

Please find attached addendum to the notice of 24th Annual General Meeting.

AGM/EGM / AGM View filing →
17 August 2026

Book Closure

Intimation Of Record Date, E-Voting Dates And Book Closure Date

Intimation of Record date, E-Voting dates and Book Closure date.

Corp. Action / Book Closure View filing →
14 August 2026

Newspaper Publication

Newspaper Publication

Newspaper publication dated 14th August 2026 of Unaudited Financial Results for the quarter ended 30th June 2026.

Company Update / Newspaper Publication View filing →
13 August 2026

Newspaper Publication

Newspaper Publication

Newspaper publication regarding 24th AGM of the Company to be held on 3rd September 2026.

Company Update / Newspaper Publication View filing →
13 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 13Th August, 2026

Outcome of Board Meeting held on Thursday, 13th August, 2026

Board Meeting / Outcome of Board Meeting View filing →
13 August 2026

Results

Results - Financial Results For June 30, 2026.

Financial Results for quarter ended June 30,2026.

Result / Financial Results View filing →
12 August 2026

Annual Report

Reg. 34 (1) Annual Report.

Pursuant to Regulation 34 read with Regulation 30 of SEBI Listing Regulations, we are enclosing herewith the following: 1. Notice of the AGM.2. Annual Report for the Financial Year 2025-26.

Others / Reg. 34 (1) Annual Report View filing →
12 August 2026

AGM / EGM

Shareholder Meeting- AGM On 3Rd September 2026.

Notice of 24th Annual General Meeting of the Company to be held on 3rd September 2026 through VC/OAVM.

AGM/EGM / AGM View filing →
12 August 2026

General

Letter To The Shareholders - Annual Report For The FY 2025-26.

Letter to the Shareholders-Annual Report for the FY 2025-26

Company Update / General View filing →
7 August 2026

Newspaper Publication

Newspaper Publication

Newspaper Advertisement - Intimation of 24th Annual General Meeting of the Company through VC/OAVM.

Company Update / Newspaper Publication View filing →
6 August 2026

Board Meeting

Board Meeting Intimation for Under Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')

Brooks Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve and take on record the ....

Board Meeting / Board Meeting View filing →
17 July 2026

Change in Management

Change in Management

Appointment of Mr. Rajesh Mahajan as President - Trading.

Company Update / Change in Management View filing →
16 July 2026

Contract / MoU

Memorandum of Understanding /Agreements

We hereby inform that, further to the disclosure made by the Company on 19th June 2026 regarding proposed sale of a portion of its shareholding in Brooks Steriscience Limited.

Company Update / Memorandum of Understanding /Agreements View filing →
9 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018 for quarter ended 30th June 2026.

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
2 July 2026

General

Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Inc orporation Of Wholly Owned Subsidiary.

Intimation of Inc orporation of Wholly Owned Subsidiary.

Company Update / General View filing →
23 June 2026

Trading Window

Closure of Trading Window

Intimation of Closure of Trading Window.

Insider Trading / SAST / Closure of Trading Window View filing →
19 June 2026

General

Partial Sale Of Equity Shares Held In Brooks Steriscience Limited

We hereby inform that the Company at its board meeting held today i.e 19th June 2026 has approved sale of 51,220 equity shares held by the Company in Brooks Steriscience Limited to Steriscience ....

Company Update / General View filing →